HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+4.96%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.76B
AUM Growth
+$1.76B
(+8.9%)
Cap. Flow
+$107M
Cap. Flow
% of AUM
6.09%
Top 10 Holdings %
Top 10 Hldgs %
59.44%
Holding
77
New
20
Increased
16
Reduced
11
Closed
25
Top Buys
| 1 |
HCA Healthcare
HCA
|
$122M |
| 2 |
Edwards Lifesciences
EW
|
$121M |
| 3 |
AKRX
Akorn, Inc.
AKRX
|
$75.3M |
| 4 |
CVRS
CORINDUS VASCULAR ROBOTICS, INC
CVRS
|
$70.1M |
| 5 |
RAD
Rite Aid Corporation
RAD
|
$56.3M |
Top Sells
| 1 |
Viatris
VTRS
|
$68M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$64.2M |
| 3 |
Biogen
BIIB
|
$64.1M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$56.2M |
| 5 |
Boston Scientific
BSX
|
$42.4M |
Sector Composition
| 1 | Healthcare | 68.05% |
| 2 | Financials | 5.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Arbutus Biopharma
ABUS
$753M
| $20.5M | 1.03% |
1,725,000
+1,006,200
| +140% | +$11.9M |
|
|
TSRO
27
DELISTED
TESARO, Inc.
TSRO
| $16.3M | 0.82% |
276,647
-648,353
| -70% | -$38.1M |
|
|
28
Biogen
BIIB
$20.5B
| $13M | 0.65% |
32,140
-158,560
| -83% | -$64.1M |
|
29
Abbott
ABT
$230B
| $11.3M | 0.57% |
+229,830
| New | +$11.3M |
|
30
Sarepta Therapeutics
SRPT
$1.98B
| $11.1M | 0.56% |
365,000
-97,700
| -21% | -$2.97M |
|
31
Zoetis
ZTS
$67.6B
| $10.9M | 0.55% |
+225,530
| New | +$10.9M |
|
32
Assembly Biosciences
ASMB
$185M
| $9.73M | 0.49% |
42,114
+2,531
| +6% | +$585K |
|
|
KND
33
DELISTED
Kindred Healthcare
KND
| $9.16M | 0.46% |
451,206
-1,509,594
| -77% | -$30.6M |
|
34
Collegium Pharmaceutical
COLL
$1.25B
| $8.45M | 0.43% |
+473,664
| New | +$8.45M |
|
35
IQVIA
IQV
$31.4B
| $8.42M | 0.42% |
116,000
+19,504
| +20% | +$1.42M |
|
|
AGN
36
DELISTED
Allergan plc
AGN
| $8.35M | 0.42% |
+27,510
| New | +$8.35M |
|
|
HSTO
37
DELISTED
Histogen Inc. Common Stock
HSTO
| $5.25M | 0.26% |
+5,098
| New | +$5.25M |
|
|
ACGN
38
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $4.95M | 0.25% |
9,826
+1,245
| +15% | +$628K |
|
|
39
Teva Pharmaceuticals
TEVA
$21.5B
| $3.74M | 0.19% |
63,200
-1,086,800
| -95% | -$64.2M |
|
|
CYAD
40
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
| $3.38M | 0.17% |
+65,000
| New | +$3.38M |
|
41
Thermo Fisher Scientific
TMO
$183B
| $3.05M | 0.15% |
23,480
-44,620
| -66% | -$5.79M |
|
|
ELOS
42
DELISTED
Syneron Medical Ltd
ELOS
| $2.8M | 0.14% |
263,400
| – | – |
|
|
IPCM
43
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| $2.57M | 0.13% |
+46,300
| New | +$2.57M |
|
44
Tandem Diabetes Care
TNDM
$834M
| $2.16M | 0.11% |
+19,960
| New | +$2.16M |
|
45
Universal Health Services
UHS
$11.6B
| $2.12M | 0.11% |
14,900
-210,100
| -93% | -$29.9M |
|
|
OREX
46
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $2.1M | 0.11% |
+42,500
| New | +$2.1M |
|
47
Tenet Healthcare
THC
$16.5B
| $1.6M | 0.08% |
+27,700
| New | +$1.6M |
|
48
Catalyst Pharmaceutical
CPRX
$2.42B
| $1.59M | 0.08% |
+385,500
| New | +$1.59M |
|
49
Agilent Technologies
A
$35.5B
| – | – |
-525,000
| Closed | -$21.8M |
|
50
Akebia Therapeutics
AKBA
$827M
| – | – |
-594,534
| Closed | -$6.61M |
|